Clinical trials underway for 15 new drugs
The Korea Food and Drug Administration announced that clinical trials are underway for 15 new drugs by domestic and foreign-invested pharmaceutical firms in Korea. Details:
|
Product (ingredient) |
Company |
Current status (indication) |
|
Gemzar (gemcitabine) inj. 200mg, 1g |
Li... |
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
